Literature DB >> 11267205

Fast quantification method for sirolimus and its major metabolites.

G I Kirchner1, W Jacobsen, M Deters, U Christians, B Nashan, M Winkler, C Vidal, V Kaever, K Sewing, M P Manns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11267205     DOI： 10.1016/s0041-1345(00)02430-1

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

Review 1.  Sirolimus: the evidence for clinical pharmacokinetic monitoring.

Authors:  Sunita Bond Stenton; Nilufar Partovi; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

2.  Sirolimus/cyclosporine/tacrolimus interactions on bile flow and biliary excretion of immunosuppressants in a subchronic bile fistula rat model.

Authors:  Michael Deters; Til Klabunde; Gabriele Kirchner; Klaus Resch; Volkhard Kaever
Journal:  Br J Pharmacol       Date:  2002-06       Impact factor: 8.739

3.  FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo.

Authors:  D Cejka; C Kuntner; M Preusser; M Fritzer-Szekeres; B J Fueger; S Strommer; J Werzowa; T Fuereder; T Wanek; M Zsebedics; M Mueller; O Langer; V Wacheck
Journal:  Br J Cancer       Date:  2009-05-12       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.